Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Cartesian Therapeutics Inc (RNAC)

Cartesian Therapeutics Inc (RNAC)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
10.00 -2.34 (-18.96%) 04/04/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 10.00 unch (unch) 16:00 ET
Quote Overview for Fri, Apr 4th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
9.12
Day High
12.10
Open 12.01
Previous Close 12.34 12.34
Volume 340,900 340,900
Avg Vol 113,390 113,390
Stochastic %K 12.05% 12.05%
Weighted Alpha -53.12 -53.12
5-Day Change -4.54 (-31.22%) -4.54 (-31.22%)
52-Week Range 9.12 - 41.87 9.12 - 41.87
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 319,692
  • Shares Outstanding, K 25,907
  • Annual Sales, $ 38,910 K
  • Annual Income, $ -77,420 K
  • EBIT $ -54 M
  • EBITDA $ -52 M
  • 60-Month Beta 0.55
  • Price/Sales 8.62
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.61
  • Number of Estimates 3
  • High Estimate -0.55
  • Low Estimate -0.65
  • Prior Year -1.97
  • Growth Rate Est. (year over year) +69.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.12 +9.65%
on 04/04/25
Period Open: 17.84
18.80 -46.81%
on 03/11/25
-7.84 (-43.95%)
since 03/04/25
3-Month
9.12 +9.65%
on 04/04/25
Period Open: 16.85
20.12 -50.30%
on 01/16/25
-6.85 (-40.65%)
since 01/03/25
52-Week
9.12 +9.65%
on 04/04/25
Period Open: 15.12
41.87 -76.12%
on 06/06/24
-5.12 (-33.88%)
since 04/04/24

Most Recent Stories

More News

Business Summary

Cartesian Therapeutics is a clinical-stage company pioneering RNA cell therapies for the treatment of autoimmune diseases. The company's lead asset, Descartes-08, is a potential first-in-class, RNA-engineered chimeric antigen receptor T-cell therapy in Phase 2b clinical development for patients with...

See More

Key Turning Points

3rd Resistance Point 14.67
2nd Resistance Point 13.39
1st Resistance Point 11.69
Last Price 10.00
1st Support Level 8.71
2nd Support Level 7.43
3rd Support Level 5.73

See More

52-Week High 41.87
Fibonacci 61.8% 29.36
Fibonacci 50% 25.49
Fibonacci 38.2% 21.63
Last Price 10.00
52-Week Low 9.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades